Compliance with a three-day course of artesunate-mefloquine combination and baseline anti-malarial treatment in an area of Thailand with highly multidrug resistant falciparum malaria

Malaria Journal

Volumn 9, Issue 1, 2010, Pages

  Congpuong, Kanungnit ^a   Bualombai, Pongwit ^a   Banmairuroi, Vick ^b   Na Bangchang, Kesara ^b  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

^b THAMMASAT UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; DIMENHYDRINATE; MEFLOQUINE; PARACETAMOL; PRIMAQUINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; MULTIDRUG RESISTANCE; PATIENT COMPLIANCE; PRESCHOOL CHILD; SCHOOL CHILD; THAILAND; TREATMENT OUTCOME; VOMITING; DRUG ADMINISTRATION; DRUG COMBINATION; DRUG EFFECT; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PARASITEMIA; PLASMODIUM FALCIPARUM;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; MEFLOQUINE; MIDDLE AGED; PARASITEMIA; PATIENT COMPLIANCE; PLASMODIUM FALCIPARUM; THAILAND; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77749280080     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-9-43     Document Type: Article

References (30)

1. Effects of artemisinin derivatives on malaria transmissibility. RN Price F Nosten C Luxemburger FO ter Kuile L Paiphun T Chongsuphajaisiddhi NJ White, Lancet 1996 347 1654 1658
2. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in estern Thailand: a prospective study. F Nosten M van Vugt R Price C Luxemburger KL Thway A Brockman R McGready F ter Kuile S Looareesuwan NJ White, Lancet 2000 356 297 302
3. Artemisinin-based combination therapy reduces expenditure on malaria treatment in KwaZulu Natal, South Africa. C Muheki D McIntyre KI Barnes, Trop Med Int Health 2004 9 959 966
4. Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Ntal, South Africa. KI Barnes DN Durrheim F Little A Jackson U Mehta E Allen SS Dlamini J Tsoka B Bredenkamp DJ Mthembu NJ White BL Sharp, PLoS Med 2005 2 330
5. Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria Initiative. VI Carrara S Sirilak J Thonglairuam C Rojanawatsirivet S Proux V Gilbos A Brockman EA Ashley R McGready S Krudsood S Leemingsawat S Looareesuwan P Singhasivanon N White F Nosten, PLoS Med 2006 3 183
6. An open label randomized comparison of mefloquine-artesunate as separate tablets vs. a new co-formulated combination for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand. EA Ashley KM Lwin R McGready WH Simon L Phaiphun S Proux N Wangseang W Taylor K Stepniewska W Nawamaneerat KL Thwai M Barends W Leowattana P Olliaro P Singhasivanon NJ White F Nosten, Trop Med Int Health 2006 11 1653 1660
7. A randomized trial of artemether-lumefantrine versus mefloquine- artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand. R Hutagalung L Paiphun EA Ashley R McGready A Brockman KL Thwai P Singhasivanon T Jelinek NJ White FH Nosten, Malar J 2005 4 46
8. Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy. R McGready A Brockman T Cho D Cho M van Vugt C Luxemburger T Chongsuphajaisiddhi NJ White F Nosten, Trans R Soc Trop Med Hyg 2000 94 689 693
9. Investigation of bioavailability, pharmacokinetics and safety of new pediatric formulations of artesunate and mefloquine. L Chanthap R Tsuyuoka K Na-Bangchang N Nivanna D Suksom T Sovannarith D Socheat, Southeast Asian J Trop Med Public Health 2005 36 34 43
10. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development. K Na-Bangchang J Karbwang, Fundam Clin Pharmacol 2009 23 387 409
11. The efficacy of combined mefloquine-artesunate versus mefloquine-primaquine on subsequent development of Plasmodium falciparum gametocytemia. Y Suputtamongkol S Chindarat S Silpasakorn S Chaikachonpatd K Lim K Chanthapakajee N Kaewkaukul V Thamlikitkul, Am J Trop Med Hyg 2003 68 620 623
12. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development. K Na-Bangchang J Karbwang, Fundam Clin Pharmacol 2009 23 387 409
13. World Health Organization, World Malaria Report of a WHO ScientificGroup. World Health Organization, Geneva, Thailand 2008
14. Determination of mefloquine in biological fluids using high performance liquid chromatography. J Karbwang P Molunto K Na Bangchang D Bunnag, Southeast Asian J Trop Med Public Health 1989 20 55 60 (Pubitemid 19190847)
15. Pharmacokinetics of primaquine in G6PD deficient and G6PD normal patients with vivax malaria. K Na-Bangchang W Songsaeng A Thanavibul P Choroenlarp J Karbwang, Trans R Soc Trop Med Hyg 1994 88 220 222 (Pubitemid 24139696)
16. Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria. R Price JA Simpson P Teja-Isavatharm MM Than C Luxemburger DG Heppner T Chongsuphajaisiddhi F Nosten NJ White, Antimicrob Agents Chemother 1999 43 341 346
17. The influence of body weight on the pharmacokinetics of mefloquine. JA Simpson L Aarons R Price NJ White, Br J Clin Pharmacol 2002 53 337 338
18. Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria. EA Ashley K Stepniewska N Lindegårdh R McGready R Hutagalung R Hae P Singhasivanon NJ White F Nosten, Antimicrob Agents Chemother 2006 50 2281 2285
19. Clinical pharmacokinetics of mefloquine. J Karbwang NJ White, Clin Pharmacokinet 1990 19 264 279
20. A systematic review of the associations between dose regimens and medication compliance. AJ Claxton J Cramer C Pierce, Clin Ther 2001 23 1296 1310
21. Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. JY Lee JW Kusek PG Greene, Am J Hypertens 1996 9 719 725
22. Effect of medication dosing frequency on adherence in chronic diseases. SD Saini P Schoenfeld K Kaulback MC Dubinsky, Am J Manag Care 2009 15 22 33
23. Compliance with a 2 day course of artemether-mefloquine in an area of highly multi-drug resistant Plasmodium falciparum malaria. K Na-Bangchang K Congpuong J Sirichaisinthop K Suprakorb J Karbwang, Br J Clin Pharmacol 1997 43 639 642
24. Initial evaluation of low-dose phenobarbital as an indicator of compliance with antimalarial drug treatment. J Karbwang W Fungladda CE Pickard S Shires A Hay M Feely, Bull World Health Organ 1998 76 67 73
25. Compliance with artesunate and quinine + tetracycline treatment of uncomplicated falciparum malaria in Thailand. W Fungladda ER Honrado K Thimasarn D Kitayaporn J Karbwang P Kamolratanakul R Masngammueng, Bull World Health Organ 1998 76 Suppl 1 59 66
26. Impact of pre-packaging antimalarial drugs and counselling on compliance with malaria treatment at Port Moresby General Hospital Adult Outpatient Department. JA Lauwo FW Hombhanje SP Tulo G Maibani S Bjorge, P N G Med J 2006 49 14 21
27. Drugs for Neglected Disease Initiative. http:///www.dndi.org
28. Impact of prepackaging antimalarial drugs on cost to patients and compliance with treatment. K Yeboah-Antwi JO Gyapong IK Asare G Barnish DB Evans S Adjei, Bull World Health Organ 2001 79 394 399
29. Pharmacokinetics of mefloquine in treatment failure. J Karbwang K Na-Bangchang A Thanavibul D Bunnag T Harinasuta, Southeast Asian J Trop Med Public Health 1991 22 523 526
30. Incidence of antimalarial pretreatment and drug sensitivity in vitro in multidrug-resistant Plasmodium falciparum infection in Thailand. K Congpuong J Sirtichaisinthop P Tippawangkosol K Suprakrob K Na-Bangchang P Tan-ariya J Karbwang, Trans R Soc Trop Med Hyg 1998 92 84 86